
open access
메뉴
E-ISSN : 2671-6771
Drosophila melanogaster has served as one of the most powerful and versatile model organisms in biomedical research for over a century. Its high degree of genetic conservation with humans, with approximately 75% of human disease-associated genes having functional orthologs in the fly, combined with sophisticated genetic tools and a short generation time, makes it uniquely suited for investigating the mechanisms underlying human diseases. This review provides a comprehensive overview of the utility of Drosophila in rare disease research, highlighting its contributions across multiple disease categories, including neurological and neurodevelopmental disorders, metabolic and mitochondrial diseases, lysosomal storage disorders, sensory disorders, immunological conditions, and cancer. We discuss the technical advantages that make the fruit fly an ideal first-line model for functional genomics, including the GAL4/UAS system, CRISPR/Cas9 gene editing, and humanization strategies. Furthermore, we examine the inherent limitations of the fly model and the innovative approaches developed to overcome them, such as the integration of complementary model systems and the expression of human disease genes in flies. As rare diseases continue to pose significant diagnostic and therapeutic challenges, Drosophila remains an indispensable platform for elucidating disease mechanisms, validating patient-derived genetic variants, and identifying potential therapeutic targets.